Renal Cell Cancer

This page contains recent news articles, when available, and an overview of Renal Cell Cancer but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Renal Cell Cancer

Patients with Metastatic Renal Cell Cancer Are Diagnosed Earlier and Have More ...  -  23 Nov 2009
Cancer ConsultantsResearchers from Memorial Sloan Kettering have reported that the proportion of patients with metastatic renal cell cancer with favorable risk features has ...

$10 million donation could revolutionize cancer treatment  -  23 Nov 2009
Bakersfield NowNow, he says they're focusing on melanoma and renal cell cancer. Other targets they're working on include breast cancer, prostate cancer and colon cancer ...

Transperitoneal laparoscopic right radical nephrectomy for renal cell ...  -  ‎Nov 18, 2009‎
7thSpace Interactive (press release)However, in patients with end-stage renal disease, radical nephrectomy emerges as a more efficient treatment for localized renal cell cancer. ...

Multidisciplinary meeting on urological cancers aims to benefit cancer patients  -  ‎Nov 19, 2009‎
Genetic Engineering News (press release)The meeting enables experts to present the most recent advances in prostate, bladder and renal cell cancer and spans the entire field; from bench research ...

Bariatric Surgery: a year long journey  -  ‎Nov 18, 2009‎
WAOWThe tumor was Renal Cell Cancer, found at just the right time. "When we go in for doing this laparoscopic surgery we don't nearly ever look at the kidneys. ...

Clinical and molecular genetic aspects of hereditary multiple cutaneous ...  -  ‎Nov 20, 2009‎
John Libbey EurotextIn 2001, Launonen et al. reported that a small proportion of families with MCUL also cluster renal cell cancer (RCC) [8]. The latter disease variant is ...

Eli Sercarz dies at 75; UCLA scientist made key discoveries in immunology  -  ‎Nov 20, 2009‎
Los Angeles Times...the mechanisms of autoimmunity and developed key concepts about how the body's immune system attacks its own tissues, died of renal cell cancer Nov. ...

Former GI superintendent passes away  -  ‎Nov 17, 2009‎
KHAS-TVDr. Kneale was diagnosed with Renal Cell Cancer more than 20 years ago. Doctors told him when he was first diagnosed he would only live 14 months. ...

Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and ...  -  ‎Nov 5, 2009‎
Reuters..."We are pleased to have presented clinical data of IMO-2055 in renal cell cancer and in non-small cell lung cancer. We look forward to presenting data from ...

Low-dose Interferon-alfa Does Not Improve Outcomes of Patients with Renal Cell ...  -  ‎Nov 4, 2009‎
Cancer Consultants...[2] Phase II trial of sorafenib plus interferon alfa-2b as first-or second-line therapy in patients with metastatic renal cell cancer. ...

Highly regarded scientist was leader in field of immunology  -  ‎Nov 18, 2009‎
San Diego Union TribuneDr. Sercarz died of renal cell cancer Nov. 3 at his Topanga home. He was 75. Dr. Sercarz, who had worked in San Diego since 1997, split his time between ...

Continuous Daily Sutent® Palliative in Patients with Relapsed or Refractory ...  -  ‎Nov 5, 2009‎
Cancer ConsultantsSutent is approved for the treatment of advanced renal cell cancer, as well as for the treatment of gastrointestinal stromal tumors after disease ...

Synta Pharmaceuticals Corp. Q3 2009 Earnings Call Transcript  -  ‎Nov 4, 2009‎
Seeking Alpha (blog)The second case is a patient with an advance metastatic renal cell cancer. This patient also exhausted all center of are treatment options for his disease. ...

Bionomics CEO confident anti cancer and anxiety clinical milestones can be ...  -  ‎Nov 4, 2009‎
Proactive Investors was decided the first Phase II clinical trial of BNC105 will be in patients with renal cell cancer (a form of kidney cancer). ...

Llega a la Argentina una nueva alternativa terapéutica para el cáncer de riñón.  -  ‎Nov 9, 2009‎
Noticias Médicas (Comunicado de prensa)La solicitud de aprobación para everolimus presentada ante la FDA y la EMEA se basa en datos del estudio RECORD-1 (por su sigla en inglés, REnal Cell cancer ...

Avastin® Approved for Kidney Cancer  -  07 Aug 2009
Cancer ConsultantsRenal cell cancer (RCC) is a malignancy involving these tubules of the kidney. Avastin is a targeted therapy that blocks a protein known as VEGF.

Tumor perfusion assessed by dynamic contrast-enhanced MRI ...  -  07 Aug 2009
UroTodayA total of 21 patients with suspected renal cell cancer were examined using a Gadobutrol-enhanced, dynamic saturation-recovery, turbo-fast, low-angle shot

Roche's Avastin FDA Approved for Metastatic Kidney Cancer  -  ‎Aug 4, 2009‎
Gerson Lehrman GroupTo date, only one drug, Torisel by Wyeth, has demonstrated an overall survival benefit in high risk patients with metastatic renal cell cancer.

Interferon Plus Sunitinib or Bevacizumab Improves Metastatic Renal ...  -  ‎Jul 30, 2009‎
Cancerpage.comNEW YORK (Reuters Health) - In patients with metastatic renal cell carcinoma, first-line treatment with interferon (IFN)-alpha plus sunitinib or bevacizumab

Make-A-Wish grants teenagers's dream to travel  -  ‎Aug 2, 2009‎
Martinsburg JournalAccording to the American Cancer Society, renal cell carcinoma, also known as renal cell cancer or renal cell adenocarcinoma, is the most common type of

Research and Markets: 2009 BioMedTracker Outlook Report - Insight ...  -  ‎Aug 6, 2009‎
Business Wire (press release) (press release)...and breast cancer and has the potential to be approved for use in two additional indications, glioblastoma multiforme (GBM) and renal cell cancer (RCC).

Moderate Alcohol Intake and Cancer Incidence in Women  -  ‎Jul 17, 2009‎
MedscapeAlcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst (2007) 99(10):801-810. Mack WJ, Preston-Martin S,

Gemcitabine and capecitabine chemotherapy in Japanese patients ...  -  ‎Jul 20, 2009‎
UroTodayGemcitabine and capecitabine chemotherapy can be safely administered as second-line therapy in renal cell cancer patients, maintaining QOL baseline

Active Biotech AB's Cancer Project ANYARA Featured in Journal of ...  -  ‎Jul 29, 2009‎
Lifescience-onlineANYARA is presently in development primarily for the treatment of renal cell cancer. A pivotal phase III study, which has completed enrollment of over 500

Multiple Tender Papules in a 48-Year-Old Man—Diagnosis  -  ‎Jul 20, 2009‎
Archives of DermatologyMissense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn. 2005;7(4):437-443.

AVEO Pharmaceuticals to Present at the Canaccord Adams 29 th ...  -  ‎Aug 4, 2009‎
Business Wire (press release)...recently completed Phase 2 clinical development in patients with metastatic renal cell cancer and is expected to enter Phase 3 development in 2009.

High Risk Renal Cell Carcinoma Surgery Successfully Performed at ...  -  ‎Jul 13, 2009‎
Express Healthcare ManagementAccording to Dr Ashwin Garg, Consultant, Centre for Interventional Radiology, Moolchand Medcity, "Renal cell cancer, which has the propensity for rapid

AVEO's Tivozanib Demonstrates Anti-Tumor Activity in Engineered ...  -  ‎Aug 1, 2009‎ (press release)...recently completed Phase 2 clinical development in patients with metastatic renal cell cancer and is expected to enter Phase 3 development in 2009.

Avastin(R) (bevacizumab) Now Approved For Use In Combination With ...  -  ‎Jul 31, 2009‎
Medical News Today (press release)...and/or overall survival benefit for patients in four types of metastatic/advanced cancer: colorectal, breast cancer, lung and renal cell cancer.

Successful - DGAP-News: WILEX AG: WILEX reports on the first half ...  -  ‎Jul 13, 2009‎
Ad-Hoc-News (Pressemitteilung)The trial aims to determine whether the PET/CT procedure using REDECTANE(R) improves the diagnosis of clear cell renal cell cancer compared to CT,

What Is Radiotherapy? What Is Radiation Therapy?  -  ‎Jul 23, 2009‎
Medical News TodayExamples are renal cell cancer and melanoma. Metastatic cancers, regardless of how radiosensitive they are, are usually incurable with radiotherapy because

OSI Pharmaceuticals and AVEO Pharmaceuticals Expand Oncology ...  -  ‎Jul 22, 2009‎ (press release)...recently completed Phase 2 clinical development in patients with metastatic renal cell cancer and is expected to enter Phase 3 development in 2009.

Smoking, environmental tobacco smoke and risk of renal cell cancer ...  -  Dec 24, 2008
7thSpace Interactive (press release),Kidney and renal pelvis cancers account for 4% of all new cancer cases in the United States, among which 85% are renal cell carcinomas (RCC).

GOLPH2 Expression in Renal Cell Cancer - Abstrac  -  Dec 7, 2008
UroToday,Renal cell carcinomas (RCC) are among the most common and most lethal genitourinary malignancies. GOLPH2 (golgi phosphoprotein 2, GOLM1) has recently been

Class I histone deacetylases 1, 2 and 3 are highly expressed in ...  -  Dec 19, 2008
7thSpace Interactive (press release),However, little is known about HDAC expression in renal cell cancer. Methods: We investigated the expression of HDAC 1, 2 and 3 in 106 renal cell carcinomas

Study: Meat, Fat, Protein Don’t Increase Risk of Renal Cancer  -  Dec 2, 2008
Food Product Design,A total of 1478 incident cases of renal cell cancer were identified (709 in women; 769 in men). Researchers noted: “We observed statistically significant

Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 ...  -  Dec 9, 2008
Stockhouse,...including metastatic renal cell cancer, hepatocellular carcinoma, melanoma, carcinoid, prostate, head and neck, breast, and small cell lung cancer.

Saints owner Benson has cancer surgery  -  Dec 17, 2008
United Press InternationalAmoss said the 3-centimeter mass was found during a CT scan and diagnosed as early-stage renal cell cancer. The disease had not spread.

Active Biotech's Cancer Project ANYARA: Combination with ...  -  Dec 10, 2008
FOXBusinessANYARA is presently developed primarily for the treatment of Renal Cell Cancer. A pivotal phase III study, which will encompass a total of 500 patients,

UK Kidney Cancer Patients Face Toxic, Out-dated Treatments With ...  -  Dec 9, 2008
Science Daily (press release)Eisen T. The National Institute of Health and Clinical Excellence rejects new treatments for renal cell cancer: Cinderella's invitation is cancelled.

Bush out for final two games  -  Dec 18, 2008
2TheAdvocate,Team physician Dr. John Amoss said the mass was frozen and removed and then diagnosed as early-stage renal cell cancer.

Interim Announcement: MOLOGEN AG : Publication Of An Interim ...  -  Dec 19, 2008
ABN Newswire (press release),Pre-clinical development work for the preparations of a clinical study with cell-based gene therapy against renal cell cancer (MGN1601) is almost complete.

Kidney cancer : Genes linked to fat metabolism may increase kidney ...  -  Dec 5, 2008
Newspost Online,This is the first and largest study of renal cell cancer to evaluate the influence of these genes,? Moore added. For the study, the researchers examined

Background information on Renal Cell Cancer [When available]

Renal cell carcinoma, also known by the eponym Grawitz tumor, is the most common form of kidney cancer arising from the renal tubule. It is the most common type of kidney cancer in adults. Initial therapy is with surgery. It is notoriously resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy.

Search the web for more resources on Renal Cell Cancer

Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

The Cancer News Network


Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on lead to other sites. does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is responsible for dead or misdirected links.

We will do our best to accommodate your request.